Literature DB >> 25724710

Attitudes Toward Pre-implantation Genetic Diagnosis (PGD) for Genetic Disorders Among Potential Users in Malaysia.

Angelina Patrick Olesen1, Siti Nurani Mohd Nor2,3, Latifah Amin4.   

Abstract

While pre-implantation genetic diagnosis (PGD) is available and legal in Malaysia, there is an ongoing controversy debate about its use. There are few studies available on individuals' attitudes toward PGD, particularly among those who have a genetic disease, or whose children have a genetic disease. To the best of our knowledge, this is, in fact, the first study of its kind in Malaysia. We conducted in-depth interviews, using semi-structured questionnaires, with seven selected potential PGD users regarding their knowledge, attitudes and decisions relating to the use PGD. The criteria for selecting potential PGD users were that they or their children had a genetic disease, and they desired to have another child who would be free of genetic disease. All participants had heard of PGD and five of them were considering its use. The participants' attitudes toward PGD were based on several different considerations that were influenced by various factors. These included: the benefit-risk balance of PGD, personal experiences of having a genetic disease, religious beliefs, personal values and cost. The study's findings suggest that the selected Malaysian participants, as potential PGD users, were supportive but cautious regarding the use of PGD for medical purposes, particularly in relation to others whose experiences were similar. More broadly, the paper highlights the link between the participants' personal experiences and their beliefs regarding the appropriateness, for others, of individual decision-making on PGD, which has not been revealed by previous studies.

Entities:  

Keywords:  Malaysia; Personal experiences; Playing God; Pre-implantation genetic diagnosis (PGD); Reproductive rights

Mesh:

Year:  2015        PMID: 25724710     DOI: 10.1007/s11948-015-9639-z

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  14 in total

1.  On new reproductive technologies and family ethics: pre-implantation genetic diagnosis for sibling donor in Israel and Germany.

Authors:  Yael Hashiloni-Dolev; Shiri Shkedi
Journal:  Soc Sci Med       Date:  2007-07-31       Impact factor: 4.634

2.  Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.

Authors:  Elizabeth Ormondroyd; Louise Donnelly; Clare Moynihan; Cornelie Savona; Elizabeth Bancroft; D Gareth Evans; Rosalind Eeles; Stuart Lavery; Maggie Watson
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

3.  Preimplantation genetic diagnosis principles and ethics.

Authors:  S J Fasouliotis; J G Schenker
Journal:  Hum Reprod       Date:  1998-08       Impact factor: 6.918

4.  Christian lay understandings of preimplantation genetic diagnosis.

Authors:  Bill Doolin; Judy Motion
Journal:  Public Underst Sci       Date:  2010-11

5.  Opinions about new reproductive genetic technologies: hopes and fears for our genetic future.

Authors:  Andrea L Kalfoglou; Teresa Doksum; Barbara Bernhardt; Gail Geller; Lisa LeRoy; Debra J H Mathews; John H Evans; David J Doukas; Nancy Reame; Joan Scott; Kathy Hudson
Journal:  Fertil Steril       Date:  2005-06       Impact factor: 7.329

6.  Attitudes of high-risk women toward preimplantation genetic diagnosis.

Authors:  Gwendolyn Quinn; Susan Vadaparampil; Crystal Wilson; Lindsey King; Jimin Choi; Cheryl Miree; Sue Friedman
Journal:  Fertil Steril       Date:  2008-04-28       Impact factor: 7.329

7.  Preimplantation genetic diagnosis: choosing the "good enough" child.

Authors:  Helen Watt
Journal:  Health Care Anal       Date:  2004-03

Review 8.  Conceptualizing couples' decision making in PGD: emerging cognitive, emotional, and moral dimensions.

Authors:  Patricia E Hershberger; Penny F Pierce
Journal:  Patient Educ Couns       Date:  2010-01-08

9.  Preimplantation genetic diagnosis for beta-thalassemia using single-cell DNA analysis for codons 17 and 26 of beta-globin gene.

Authors:  Noor Wahidah Mohd Nasri; A Rahman A Jamal; Nurshaireen Chue Abdullah; Zainul Rashid Mohd Razi; Norfilza Mohd Mokhtar
Journal:  Arch Med Res       Date:  2009-01       Impact factor: 2.235

10.  Attitude towards pre-implantation genetic diagnosis for hereditary cancer.

Authors:  Chantal Lammens; Eveline Bleiker; Neil Aaronson; Annette Vriends; Margreet Ausems; Maaike Jansweijer; Anja Wagner; Rolf Sijmons; Ans van den Ouweland; Rob van der Luijt; Liesbeth Spruijt; Encarna Gómez García; Mariëlle Ruijs; Senno Verhoef
Journal:  Fam Cancer       Date:  2009-07-30       Impact factor: 2.375

View more
  5 in total

1.  Abortion of Fetus with Down's Syndrome: India Joins the Worldwide Controversy Surrounding Abortion Laws.

Authors:  Alankrita Taneja; Sharath Burugina Nagaraja; Jagadish Rao Padubidri; Mohammed Madadin; Ritesh G Menezes
Journal:  Sci Eng Ethics       Date:  2017-06-12       Impact factor: 3.525

2.  The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users.

Authors:  Shachar Zuckerman; Sigal Gooldin; David A Zeevi; Gheona Altarescu
Journal:  J Assist Reprod Genet       Date:  2020-05-27       Impact factor: 3.412

3.  Conception of Saviour Siblings: Ethical Perceptions of Selected Stakeholders in Malaysia.

Authors:  Chee Ying Kuek; Sharon Kaur A/P Gurmukh Singh; Pek San Tay
Journal:  Asian Bioeth Rev       Date:  2021-03-17

4.  Patients' preimplantation genetic testing decision-making experience: an opinion on related psychological frameworks.

Authors:  L M Pastore; C N Cordeiro Mitchell; L R Rubin; J Nicoloro-SantaBarbara; M C Genoff Garzon; M Lobel
Journal:  Hum Reprod Open       Date:  2019-10-04

5.  Comparison of Patients' Ethical Perspectives of Preimplantation Embryo Genetic Testing for Aneuploidy (PGT-A) vs. Monogenic Disorders (PGT-M).

Authors:  J Zhang; L R Rubin; H Zierhut; L M Pastore
Journal:  Reprod Sci       Date:  2021-06-15       Impact factor: 2.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.